Measuring cytokines and other markers of immune response is particularly important for understanding the underlying mechanisms of inflammatory processes, predicting disease progression, and developing targeted therapies.
The NULISA Inflammation Panels enable comprehensive measure of inflammation response with the highest level of sensitivity across ~12 logs of protein abundance.
Profiles 250+ biomarkers of inflammation and immune response from a single 25 μl sample, including low-abundance cytokines such as IL4, IL5, IL17, and IL33.
Offers multiplexed protein quantification with unprecedented precision via absolute quantification of 150+ key cytokines and markers of immune response.
See the exciting findings from a study utilizing the NULISA Inflammation Panel 250 alongside Sapient’s mass spectrometry-based discovery proteomics and metabolomics to characterize changes in inflammatory markers observed following GLP-1 therapy.
"*" indicates required fields
